Dietary supplementation of glucosamine sulfate attenuates intestinal inflammation in a mouse model of experimental colitis.

Publication Type:

Journal Article


Journal of gastroenterology and hepatology (2013)


2013, January 2014, Public Health Sciences Division


Epidemiological evidences suggested an inverse association between the use of glucosamine supplements and colorectal cancer (CRC) risk. In this study, the efficacy of glucosamine to attenuate dextran sodium sulfate (DSS)-induced colitis, a precancerous condition for CRC was evaluated.